Loading...
Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis
Cystic fibrosis (CF) is a life-limiting, multisystem disease characterized by thick viscous secretions leading to recurrent lung infections, bronchiectasis, and progressive deterioration in lung function. CF is caused by loss or dysfunction of the CF transmembrane conductance regulator (CFTR) protei...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3770629/ https://ncbi.nlm.nih.gov/pubmed/24039402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S30345 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|